The Scientist

» drug development and microbiology

Most Recent

image: Bacteria to Blame?

Bacteria to Blame?

By | August 18, 2015

T cells activated in the microbe-dense gut can spark an autoimmune eye disease, a study shows. 

2 Comments

image: Report: Impact of Biomedical Research Slipping

Report: Impact of Biomedical Research Slipping

By | August 18, 2015

Despite dramatic increases in publications, the last 50 years have seen relatively little return on investment for US public health, a study suggests.

15 Comments

image: The Search for Persisters

The Search for Persisters

By | August 11, 2015

Lyme disease–causing bacteria can outmaneuver antibiotics in vitro and manipulate the mouse immune system.

0 Comments

image: Doctor Who Blocked Thalidomide Dies

Doctor Who Blocked Thalidomide Dies

By | August 11, 2015

Frances Oldham Kelsey, a physician who halted use of a drug that caused birth defects in babies, has passed away at age 101.

0 Comments

image: Bacterial Enzyme an Antismoking Aid?

Bacterial Enzyme an Antismoking Aid?

By | August 10, 2015

A compound that degrades nicotine before it reaches the brain could serve as a successful smoking cessation therapy, according to an in vitro study.

0 Comments

image: FDA Approves 3-D–Printed Drug

FDA Approves 3-D–Printed Drug

By | August 4, 2015

The US Food and Drug Administration green lights the first medicine produced by a 3-D printer for use in the human body.

1 Comment

image: Subway Microbiome Study Revised

Subway Microbiome Study Revised

By | August 4, 2015

Researchers tone down their highly publicized study that reported the presence of deadly pathogens on New York City subways.

0 Comments

image: TB Traces

TB Traces

By | August 1, 2015

Take a trip to the mummy museum in Vác, Hungary, to see the human remains that helped researchers learn more about the origins of tuberculosis in Europe.

0 Comments

image: Anthrax Sent in Error to 86 Labs

Anthrax Sent in Error to 86 Labs

By | July 29, 2015

A US Army lab shipped live spores of the deadly bacterium because of improper irradiation protocols, a Department of Defense review has found.

1 Comment

image: Teva Buys Allergan Generics for $40.5 Billion

Teva Buys Allergan Generics for $40.5 Billion

By | July 27, 2015

Meanwhile, Allergan acquires drug developer Naurex in a $560 million deal. 

0 Comments

Popular Now

  1. Secret Eugenics Conference Uncovered at University College London
  2. Like Humans, Walruses and Bats Cuddle Infants on Their Left Sides
  3. How Do Infant Immune Systems Learn to Tolerate Gut Bacteria?
  4. Scientists Continue to Use Outdated Methods
AAAS